We are excited to welcome you back in-person to Los Angeles for ASHG’s annual meeting, taking place this October 25-29. Attendees can look forward to reconnecting with peers, engaging in discussions on research findings and sessions, all while enjoying the beautiful attractions and backdrop LA has to offer for this long-awaited reunion.

The goal is to make more products faster and more efficiently, without sacrificing quality. Before implementing change, you need to answer several core questions, including: How can I intensify an established process with minimal risk? Why should I change a working, validated process? What are the appropriate technology options and what metrics should be considered to justify their investment? Our speakers provide insight on their experiences, decision-making processes and outcomes.

Hallmarks of Cancer Cell Symposium is one of the most popular and longest-lasting conference series of Cell Press, and has been successfully held in the United States, Europe, and China previously. High-quality talks from highly respected cancer researchers and oncologists will strengthen and extend our understanding of cancer biology and accelerate the translation of the cutting-edge knowledge into more effective therapies. As a tradition, our “Meet the Speakers” dinner provides an additional great platform to communicate with leaders in the community in an interactive, productive, and relaxed environment. The year of 2022 also marks the 20th anniversary of Cancer Cell, and the meeting attendees are all invited to join our celebration of 20 years of serving this great community. After the disruption in scientific communication and social isolation imposed by lockdowns and travel restrictions, we are excited to meet you and talk about science in person. Come and join us in San Diego this fall.

CRISPR 2022 brings together investigators focused on enzymes and technologies, predominantly CRISPR-based systems, but also other promising systems and approaches, to discuss advances in the field and ways to harness genome engineering for beneficial purposes. Topics range from fundamental biology to translational and applied applications and include studies across the diversity of life. Importantly, speakers and participants represent both academic and commercial interests.

Network with 1,200 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe." Last year, nearly 900 delegates from 35 countries, including 78% from pharma and biotech organizations, convened in beautiful Barcelona and online to discuss the latest advances in protein and antibody engineering.

Join us for the ISSCR 2022 Boston International Symposium on Cell Manufacturing and Commercialization “Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success,” which will take place at the Boston Marriott Cambridge Boston, MA from 17-19 November 2022. The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies. Sessions will cover some of the latest thinking and approaches for selecting the cell line, characterizing the product and manufacturing considerations, managing the immune system, and working with regulators throughout the process. We hope you can join us in one of the world’s hubs of biotechnology.

After two years, Cell Bio 2022 will return as an in-person meeting December 3-7, 2022, in Washington, DC. We are excited to make it possible for colleagues to reconnect face-to-face, while keeping health and safety paramount. We understand flexibility is also important. In addition to our in-person meeting, limited content will be available on-demand for purchase after the meeting so that all scientists can access the cutting-edge cell biology research that was presented during the in-person meeting.

Stem cells are moving toward the clinic as cellular therapeutics in several indications and are being tested in clinical trials in others. They are also employed to advantage in the discovery of novel therapeutics in several modalities, including physiologically relevant toxicity and drug screening platforms, and lend themselves to other treatment modalities, including gene therapy, and personalized precision medicine. The goal of this Cell Symposium is to bring together clinicians, academic researchers, and industry and regulatory stakeholders to discuss advances in the field and to champion new ideas to overcome the current challenges across the clinical and translational spectrum of stem–cell-based research and therapy.

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers. International Conference on CRISPR and Gene Editing aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of CRISPR and Gene Editing. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of CRISPR and Gene Editing.

There have been tremendous advancements and breakthroughs in cell therapy treatments. Autologous treatments are extremely effective personalized therapies, but have significant medical, cost and commercialization limitations. Allogeneic treatments provide us with an opportunity to expand and extend access to personalized therapies to patients in need, but face efficacy, safety, and process hurdles. While related, the differences are stark, forcing your company to make unique and critical process and business decisions to ensure your company implements the best technologies to execute the most effective autologous and/or allogeneic cell therapy manufacturing strategy.

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below: • Novel Drug Products and Large Volume Delivery • Sustainability for Injectable Delivery Devices • Primary Packaging Development • Connected Drug Delivery Devices

PepTalk connects protein science researchers from around the globe to share case studies, unpublished data, breakthroughs, and solutions that support and enhance biotherapeutics R&D. This year’s event will feature world-renowned speakers, cutting-edge technologies, and engaging networking events. Programming includes in-depth coverage of antibody discovery, protein engineering, bispecific antibodies, emerging immunotherapies, protein aggregation, machine learning, cell and gene therapy, protein expression, purification and production.

SAE’s 2nd annual Transdermal and Microneedle Drug Delivery conference will explore advances in microneedle diagnostics through case studies and real-world examples, whilst engaging in modern strategies for topical and transdermal drug delivery. The two-day agenda offers you peer-to-peer networking with CEO’s, Senior Vice presidents, Directors of Delivery Technologies, Heads of Product Development and many more. Key considerations for the conference will be transdermal and microneedle systems as a mode of therapeutic drug delivery in combination with optimization of device design and development. Vaccine delivery will a significant aspect of this year’s agenda with a focus on microneedle delivery technologies as a mode for vaccine delivery, in the pursuit to increase vaccine stability and accessibility. An outlook of the transdermal space will also be reviewed, including future directions and next steps required to advance the current field and accelerate access for patients and end users.

The inaugural Next Generation Ophthalmic Drug Delivery Summit is coming to San Francisco in January 2023, to help ophthalmic drug developers overcome translational challenges of developing novel long-lasting ophthalmic therapies via novel delivery methods to reduce healthcare burden and increase patient compliance. Join 21+ expert speakers from the likes of Genentech, Aerie Pharmaceuticals, Novartis, Clearside Biomedical, Janssen, Eyevensys, and EyePoint Pharmaceuticals to overcome your translational challenges and enhance extended drug efficacy while avoiding systemic and local adverse effects. Don’t miss your only opportunity for an industry-specific meeting for networking and sharing extended-duration therapies with the ophthalmic drug development community.

WELCOME BACK to the annual get-together for the entire genomics and biodata community, to discover, meet, learn and celebrate! This year's Festival will bring you inspirational speakers, the latest research and clinical breakthroughs, cutting-edge technology and incredible networking opportunities. Free for 90% of attendees, the Festival is designed to help you return to work armed with dozens of new ideas and contacts, but also to keep you engaged, excited and proud of the difference your efforts make for patients.  We can't wait to welcome you back in-person, for what promises to be our largest in-person and most vibrant Festival yet. Explore this year's agenda and speakers, find out what activities are taking place, and don't forget to register early as tickets are limited. 

In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine. From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β. Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time - don't miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology! Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.

Allogeneic approaches are deemed the future of cell therapy due to their potential to reduce costs, increase accessibility and enhance availability. However as clinical readouts emerge, challenges associated with limited durability, solid tumour targeting and therapy immunogenicity are hindering their efficacies. The Allogeneic Cell Therapies Summit Europe is returning in January to capture the clinical advances of European drug developers whilst addressing the specific challenges they face in development. These include European regulatory affairs, donor selection, scalable manufacturing and therapy persistence. With continued investment and growth in the allogeneic space, join European leaders from Gadeta, Antion Biosciences, TC BioPharm, and many more, as well as the US leaders undertaking European trials. This includes Atara Bio and Adicet Bio, as they progress development of multiple cell types to produce the next-generation of safe, effective and accessible cell therapies in Europe.

As cell & gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability. The recent investments such as Novartis-Samsung Biologics $81m contract for viral vector manufacturing, Resilience raising $625m towards biomanufacturing capabilities including stable cell lines for viral vector production pave the foundation for scientific and technology innovations. With better understanding of these novel nanoparticles, developability and cell line development, the ability to optimize AAV, LV formulation and define robust CQAs are critical to drug developers’ ability to increase scalability with efficiency, reduce cost of goods and most importantly, ensure product quality control for patients.

The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers who are involved in the journey from early R&D through to creating a marketable product. Perspectives will be shared from large Ag companies, innovative AgBiotechs, key academic groups, regulatory bodies, and independent institutions working to translate cutting-edge CRISPR technology into a tangible product.

#CGTI 2023 will highlight the manufacturing challenges facing Cell & Gene Therapy, bringing clear insights and industry best practices from renowned sector leaders. Achieve a deeper understanding of the many manufacturing and industrialization burdens unique to carrying durable and curative therapies to needy patients.

The Third International Summit on Human Genome Editing will take place on 6-8 March 2023 at the Francis Crick Institute, London UK. Building on previous events held in Washington, D.C. (2015) and Hong Kong (2018), this Summit will continue the important dialogue around human genome editing. It will facilitate a global discussion on somatic and germline genome editing, including developments in clinical trials and genome editing tools such as CRISPR/Cas9. Earlier this year a three-part series of online events Looking Ahead to the Third Human Genome Editing Summit discussed some of the key topics of the meeting. The three-day summit is being organized by the Royal Society, the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences.

For almost 3 decades, the Molecular & Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. As we celebrate the 30th Anniversary and look forward to in-person networking, Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2023. Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing; and emerging technologies for spatial biology and single-cell multiomics. The new track on Digital Medicine reflects the future of precision medicine and adds coverage of artificial intelligence, digital diagnostics and digital biomarkers, digital pathology, sensors and wearables. Join us in sunny San Diego for the in-person networking you’ve come to expect from the TRI-CON and special 30th Anniversary keynotes. Don’t miss a minute of the cutting-edge 10-track scientific program with convenient on-demand viewing.

The Bioprocessing Summit Europe brings together 500+ bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies. This 3-day, 10 track meeting has quickly become a premier meeting in the European bioprocessing calendar and is regarded by many as “the fastest growing bioprocessing meeting in Europe” following record growth in 2022 – 350 to 500+ attendees - and a sold out Exhibit Hall. We look forward to seeing you in Barcelona, or online, 14-16 March 2023, with expanded content on cell and gene therapy CMC and manufacturing, educational training seminars and a vastly bigger Exhibit Hall.

The RNA Editing GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

This meeting will bring together research that encompasses basic and translational virology. We envision this meeting showcasing the ubiquity of viruses while highlighting commonalities among researchers, from technology through a standard goal of understanding how viruses behave and adapt and how this may be exploited for prediction of the next outbreak or leveraged for therapeutic development. The scientific response to SARS-CoV-2/COVID-19 continues to showcase how science has progressed, as the rapidity of basic and translational research has been second to none, while also revealing our weaknesses as a population. This meeting is both a celebration of how far virology has come and a forecast of what is next and the inroads to get us there. Our topics will include: 1) Viruses within: defining the virome; interaction with the microbiome; endogenous retroviruses in health and disease; tools and technologies 2) Viral pathogens: evolution, genomics, spread, prediction, and pandemic preparedness of emerging and re-emerging viruses 3) Virus-host interaction: immunology, genetics, and host factors 4) Viruses as therapeutics: diagnostics, phage therapy, viral vectors, and disease therapy 5) Targeting viruses: antivirals, vaccines, antibodies: lessons from the past; successes versus failures

As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing safer and more effective gene therapies to rare disease patients, key questions will be answered on how best the field can overcome regulatory, clinical, manufacturing and pricing bottlenecks to progress gene therapies into and through the clinic.

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers. International Conference on Genetic Engineering and Genome Research aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Genetic Engineering and Genome Research. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Genetic Engineering and Genome Research.

The World Oncology Cell Therapy Congress (April 2023) is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation. Demonstrating the value of innovative cell therapy products and securing access for patients is a key priority for all developers. In 2023, the World OCT Summit will become the only industry forum to add an exclusive pre-event evening networking session for clinicians looking to overcome barriers to patient access and facilitate clinical distribution of transformative cell therapy products. The congress will also redefine industry networking, with every attendee incentivized to complete a profile, enabling everyone to find and touch base with the pioneers and companies they would like to meet. The congress schedule will also be revamped and be repositioned to reflect the dynamic research environment of the cell therapy field. Our on-stage talks, panels and Q&As will come under the following themes – ‘Breakthroughs and Pipeline Advancements’, ‘New Cell Therapy Platforms and Enabling Technologies’, ‘Manufacturing at Scale and Commercialization’ – and with our pre-event evening expanding into ‘Cell Therapy Access and Clinical Trial Delivery’.

This Cell Symposium aims to bring together thought leaders within these diverse fields, provide a forum for sharing and disseminating the latest advances, and provide a common ground for cross-disciplinary discussion and collaboration between the fields to understand the role of neural regulation in organismal homeostasis and disease. Topics: Brain-body communication in regulating appetite and consummatory behavior Brain-body interaction in regulating energy balance/thermoregulation The gut-brain axis and neuro-immune interactions in metabolic disease New technologies and models for studying brain-body communication and treatments of disease The influence of genes and lifestyle on energy homeostasis, metabolism, and mental health

Please join us for a special discussion on the development, manufacturing, and analysis of DNA & RNA therapeutics utilizing both cell-based and cell-free processes. This includes the raw materials necessary for in vitro replication and/or transcription with a focus on the acquisition of high-quality nucleotides and recombinant enzymes. The meeting will also consider drug product formulations and nanoparticle delivery systems, including the associated raw materials, with lipids as a particular focus.

Industry experts will share their knowledge and we will present and discuss how to optimize technologies and process setups, manufacturing challenges, and strategies such as digitalization, modelling, automation, scaling up, single-use technology, and securing process continuity. Case studies will also be presented in this track. Attend the cell and gene therapy track to learn about the future of cell and gene therapy bioprocessing. The track includes expert talks on the considerations around manufacturing ATMPs, from closed loop systems for cell therapy to decentralized sites. We also cover the technical aspects of how to optimize AAV manufacturing, tackling increased demand for viral and non-viral vectors, and developing the next generation of vectors.

The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more. Harness the power of in-person events, form genuine connections, create valuable relationships with peers, and become part of the PEGS community. We are currently recruiting speakers to assist in the development of the scientific programming, poster abstracts, and sponsorship & exhibit requests. Limited opportunities are available to present. Submit a presentation proposal by October 21 for priority consideration.

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers. International Conference on DNA Structure and Genome Engineering aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of DNA Structure and Genome Engineering. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of DNA Structure and Genome Engineering.

The Bio-IT World Conference & Expo is the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. For over 20 years, the Event has united a community of leading life sciences, pharmaceutical, clinical, healthcare, informatics, and technology experts in the fields of biomedical research, drug discovery & development, and healthcare from around the world. During May 16-18, 2023, the Bio-IT World Conference & Expo will return to the Hynes Convention Center in Boston (with a live virtual stream as well) and once again host the conversations that connect people, ideas, and opportunities that are advancing research and innovation. Join your peers for updates from inspiring keynotes, more than 190 presentations, and 3 days of interactive discussion. Let’s continue holding each other accountable for pushing the Bio-IT community forward!

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The five-day meeting is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers. Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipment manufacturers, patient advocates, and more.

The APS Annual Convention is the premier global event in psychological science, providing a forum to share scientific findings and ideas. The program features invited and submitted content from all areas of the field so you can find outstanding programs in your area of research, as well as from other areas that may be relevant to your work. Attend the APS Annual Convention to connect with researchers from around the world, renew acquaintances, and foster new collaborations.

The 4th Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2023) will be held in Chengdu, China, during May 30-June 1, 2023. The aim of GECT is to provide a stage for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research results and development activities in Biomedicine, Clinical Application of Gene Editing, CRISPR Systems and CRISPR Technologies, Effective Delivery for Genes in Vitro, Gene Knock In and Genomic Screening, Genome Engineering and DNA repair, Single Base Editing, etc. GECT 2023 will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of CGene Editing and CRISPR Technologies.

The Polymers GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. The conference will focus on both synthetic and biologically derived polymers and all aspects of their chemistry, including synthesis, structural characterization, and applications, with particular emphasis on new methods for polymer synthesis, sustainable polymer development, and innovative applications of polymers in medicine, energy, electronics, and advanced manufacturing.

International Conference on Animal Biotechnology and Gene Editing aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Animal Biotechnology and Gene Editing. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Animal Biotechnology and Gene Editing.

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers. International Conference on Applications of Bacterial Genome Engineering aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Applications of Bacterial Genome Engineering. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Applications of Bacterial Genome Engineering.

The meeting will explore bacterial pathogens and pathogenesis from multiple perspectives, from cellular mechanisms to interbacterial interactions and community behavior, as well as pathogenesis in the complex milieu of the microbiota. The meeting will also highlight the pathogenic potential of the microbiome and explore microbiota-based and engineered antibacterial/therapeutic approaches. Our topics will include: Bacterial communication and signaling Interbacterial and interkingdom interactions Pathogen interactions with hosts and microbiomes Commensal homeostasis and dysbiosis Microbiome-based opportunities for therapy This innovative program will unite pathogenesis stalwarts with microbiome pioneers to share their collective knowledge—spanning molecules, microbes, and communities — to envision the future of infection biology research and therapeutic intervention.

The Histone and DNA Modifications GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

The Nucleic Acids GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

The Upconverting Nanoparticles GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. Upconverting nanoparticles (UCNPs) and related frequency-conversion nanomaterials find themselves at the intersection of many of today’s most important and demanding research areas including deep-tissue bio-imaging, sensing, and theranostics; solar light harvesting; neuroscience and optogenetics; nanoscale thermometry; and quantum communication. The rapidly emerging insights into fundamental – and tunable – upconverting nanomaterials properties together with fast-growing application spaces provides an exciting opportunity for the scientific exchange of unpublished data and provocative ideas that will ultimately maximize impact in the biomedical, information technology, and energy sectors. The 2023 GRC on Upconverting Nanoparticles brings together biologists, materials scientists, chemists, physicists, engineers, and theory and computational experts. It will accelerate progress and address the core challenges in this far-reaching research area, uniting world-renowned senior and junior experts. Participants will experience cutting-edge and thought-provoking invited lectures and engage in extensive scientific discussions and interaction with researchers, students, and postdoctoral fellows. Each lecture will be followed by ample time for lively discussion and question-and-answer sessions among invited speakers, discussion leaders, and all participants.

The Polyamines GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. This 2023 GRC/GRS will focus on the role of polyamines and polyamine-associated pathways in humans, animal models, microorganisms, and plants. Speaker sessions will feature topics on adult and pediatric cancers, medical genetics, aging, pathogens, and plants. Speakers have been chosen to highlight the most recent discoveries related to the biological roles of polyamines and the important clinical trials investigating polyamine-based targeting therapies for the treatment and prevention of cancer, genetic abnormalities, neurodegenerative disorders, and microbial pathogens.

The program will address the rapidly moving research on receptor-regulated calcium signaling and the critical questions that are key to establishing future therapies for cardiovascular, airway, gut, liver, immunoinflammatory, metabolic and neurological disorders. It is the only conference on this important topic that will be convened in 2023. Conference sessions will present the latest findings and promote discussion on: • Emerging new technologies to study calcium signaling • Organellar calcium signaling • Calcium signaling in metabolism and muscular and cardiovascular systems • Store operated calcium channels and TRP channels • Calcium signaling in cancer and the immune system • Calcium signaling in the nervous system • Calcium crosstalk with other signaling pathways • Calcium signaling proteins and regulatory mechanisms • New and notable session with latest breakthroughs The conference covers 11 sessions, 33 speakers, 16 junior investigator talks, and four poster sessions. The program includes two Career Development Workshops: one for postdocs and early career scientists about funding opportunities and how to write a successful grant; and a roundtable discussion with individuals from academia, industry, and publishing on the topic of career paths.

Retinal photoreceptor cells provide the critical first steps in vision, transducing incident photons into changes in membrane potential relayed via neural circuits to higher visual centers. Research on photoreceptors and their supporting epithelium, the retinal pigment epithelium (RPE), is not only essential for understanding how we see, but it has also advanced knowledge in areas such as G protein signaling, neurophysiology, and protein structure and function. In addition, fundamental photoreceptor and RPE research has been essential for new insights in the pathobiology of vision loss; blinding diseases like retinitis pigmentosa and macular degeneration result from photoreceptor degeneration that typically first appears as defects in cell biological and physiological mechanisms of the photoreceptors and/or the adjacent RPE.

The 2023 Advancing Gene Therapy conference will be held in The Westin Walthum, MA. The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access.

The scientific program will cover various aspects of CRISPR biology ranging from genetics, biochemistry, structural biology, ecology, evolution and applications. The scientific part of the meeting is planned for June 28 to 30. We hope to welcome you in Würzburg June 27 at the evening reception. A group activity is being planned for July 1.

The CMC Strategy Forum is the premier scientific meeting that brings together regulatory, industry, and academic professionals to discuss key emerging CMC issues that affect biotechnology in an open and transparent workshop format.

Overcome regulatory hurdles across non-clinical, clinical & CMC functions from pre-IND through to approval and satisfy regulatory requirements for gene therapies by demonstrating safety & efficacy

The WCBP Symposium is known as the highest-regarded annual conference addressing the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. Hear from and engage with leaders on a wide range of topics including CMC development strategies, innovative analytical characterization, global submission strategies, next-generation therapeutics & vaccines, as well as the challenges and promises of CRISPR-based therapeutics. This year, WCBP will be co-sponsored by the US FDA.

The largest and original forum for precision medicine. PMWC provides an exceptional forum for the exchange of information about the latest advances in technology, clinical implementation, research, and in all aspects related to the regulatory and reimbursement sectors.

In this free virtual event, Genetic Engineering and Biotechnology News [...]

The Gene Therapy Comparability Summit will ensure that you can establish comparability in your clinical phase of development and prove to regulators that your products are comparable when scaling up for commercialization and navigating process changes.

Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH collaborations that address scientific challenges and advance research for new treatments.

TAGC is a unique conference organized by the Genetics Society of America that offers innovative sessions that get to the heart of our shared research interests. The diverse and interdisciplinary scope of TAGC 2024 allows researchers to discover answers and explore new directions in today’s genetics and genomics research.

The 18th conference on rare disease combines recent research on genetic mechanisms involved in disease, with advances in approaches for clinical care. This year’s conference will include discussions on the use of a ‘pangenome’ to improve diagnostic yield, the role of common variants in rare disease, and new developments in prenatal and neonatal genomic screening.

Join pioneers from Commercial, Marketing, Medical Affairs, RWE, Market Access, Patient Engagement, and key stakeholders, will come together to deliver value to overcome the challenges that threaten the future viability of innovation.

Bringing together key figures from industry, regulatory bodies, patient non-profits, payers, and key service providers, this is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic. 

The 4th Gene Therapy for Muscular Disorders Summit in April will focus on gene therapies for muscular disorders to tackle the most pressing challenges and together, seek solutions to realize these novel therapeutic potentials for patients in need.

The 5th CRISPR and Beyond conference provides a forum for biomedical researchers from academia and industry working on high throughput screening, genome engineering, and variant effect interpretation to discuss perturbations at scale to understand genomes.

Meet the European CRISPR Medicine and Genomic Medicine community to discuss tools, delivery, safety, functional genomics, standards and regulations, and more. 

The RARE Drug Development Symposium, hosted by Global Genes and the Orphan Disease Center of the University of Pennsylvania, equips advocates with the knowledge, skills and connections they need to advance therapy development for their communities.

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.

This in-person and virtual public workshop will bring together rare disease patient advocates, academic researchers, regulated industry, and other key stakeholders to discuss considerations for the use of natural history study and registry data in rare disease drug development programs.

Address obstacles at each stage of translation and progress the future of cell and gene therapies to bring scientific innovation to therapeutic reality for patients worldwide.

Join 80+ patient advocacy and engagement professionals at gene therapy companies and patient advocacy groups to gain actionable insights that you can immediately implement into your own gene therapy programs, and come together with the community to develop solutions to the challenges that are unique to the gene therapy space.

Learn directly from the FDA’s regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed to provide participants with a strong, basic foundation in the FDA’s regulatory requirements, and also create awareness of current activities. Attend virtually or in-person. 

In The State of CRISPR and Gene Editing virtual summit, GEN proudly gathers a tantalizing line-up of luminaries from academia and industry to discuss the latest research developments, innovations, and advanced technologies that are expanding the CRISPR toolbox, delivering new therapies to patients and safeguarding our food supply.

The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products.

This event will focus on finding and optimizing novel vectors to increase specificity, target new cell types, expand packaging capacities, and reduce toxicity risks to create safer, cost-effective and efficacious gene therapies. 

The conference seeks to present the latest research findings in these fields and support early-career investigators, women, and other historically-excluded groups in the field of genome editing.

Learn more about RNA Therapeutics from concept to clinic from leaders across the field, including SCGE PI's Jennifer Doudna, Kiran Musunuru, and Sonia Vallabh. 

The International Summit on Cell and Gene Therapy serves as a platform to explore the fundamental concepts of these transformative therapies. The summit brings together experts from academia and industry to discuss a range of topics related to cell and gene therapy, including ethical considerations, social implications, tools, techniques, marketing strategies, and the commercialization of cell and gene therapy products. It also showcases the latest research progress in CGT and explores opportunities for further enhancements in availability and productivity of these therapies.

Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic. 

The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

The 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit is the only event dedicated entirely to lipid-based nanoparticle delivery, where we bring together 120+ experts in LNP non-clinical, delivery, particle engineering, and formulation from the likes of Teressa, Sanofi, MediciBio, CureVac.

The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems.

Join 100+ industry leaders at the 5th Gene Therapy for Ophthalmic Disorders Summit to uncover cutting-edge gene therapy breakthroughs. Harness the latest developments in vector engineering to target retinal cells more effectively with higher transduction efficiency.

This webinar will explore the utility of a Universal AAV Standard in assessing the quantity and genomic integrity of AAV vectors.

IEEE-EMBS International Conference on Health Innovations in Point of Care Technology (IEEE HI-POCT) is the premier conference in the areas of Health innovations in point-of-care technologies. In its eighth year, this IEEE EMB Strategic Conference will emphasize funding opportunities and the promise and pitfalls of the journey from idea to patient.

Join the Clinical In Vivo Gene Therapy (CIGT) team at Children’s Hospital of Philadelphia for an exciting one-day educational symposium, as we provide fundamental knowledge on the safe and effective practice of adeno-associated virus (AAV) gene therapy across medical specialties. 

The FDA Center for Biologics Evaluation and Research (CBER) is hosting a public patient listening meeting and opening a docket to better understand patient and care partner perspectives on safety considerations and long-term follow-up for approved gene therapy treatments for rare diseases.

The 2024 Policy Summit will include experts on topics such as global regulatory harmonization, clinical development challenges, the payment policy landscape, CGT investment insights, and more.

The 3rd Lipid Nanoparticles Development Summit Europe is your premier [...]

Week in RARE, presented by Global Genes, features the RARE Health Equity Forum and the RARE Advocacy Summit.

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development.

CRISPR 2024 is an exclusive conference that unites leaders from industry, government agencies, and academia to discuss the latest advancements in genome editing technologies. The program brings together experts from diverse fields to discuss how to safely and effectively translate these cutting-edge technologies to patients, while remaining mindful of the ethical implications.

During this conference, experts in the field will share their insights on targeting cancer-specific antigens, highlight rational combinations to further enhance the function of CAR engineered cells, describe ground-breaking efforts to engineer CAR engineered cells directly in vivo, and illuminate the biology and risks of viral vector integration.

By gathering real operators from the trenches who have not previously spoken out, not just talking heads, this event covers some of the biggest challenges faced by those who want to move advances out of the lab and into the world. They will discuss everything from drug development and technology invention to dealing with regulators, courting investors, and pricing and selling products.

The Reagan-Udall Foundation for the FDA, in collaboration with FDA’s Rare Disease Innovation Hub, will host a public meeting on October 16, 2024.

The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.

Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy.

This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable.

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice.

This free, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies, including immune responses, antibody testing, and redosing strategies.